Aripiprazole, a novel antipsychotic drug, preferentially increases dopamine release in the prefrontal cortex and hippocampus in rat brain

Neuroscience

• 5-HT1A Receptor 20%
• 5-HT2A Receptor 10%
• Acetylcholine Release 30%
• Antipsychotic 100%
• Aripiprazole 100%
• Atypical Antipsychotic 30%
• Brain 100%
• Clozapine 10%
• Cognition 10%
• Cognitive Function 10%
• Dopamine Receptor D2 10%
• Dopamine Release 100%
• Haloperidol 20%
• Hippocampus 100%
• Negative Syndrome 10%
• Nucleus Accumbens 50%
• Prefrontal Cortex 100%
• Receptor Antagonist 20%
• Receptor Partial Agonist 20%
• Typical Antipsychotic 10%

INIS

• acetylcholine 30%
• brain 100%
• dopamine 100%
• doses 20%
• drugs 100%
• hippocampus 100%
• nuclei 50%
• rats 100%
• receptors 40%
• symptoms 10%

Pharmacology, Toxicology and Pharmaceutical Science

• Acetylcholine 30%
• Aripiprazole 100%
• Atypical Antipsychotics 30%
• Clozapine 10%
• Dopamine 100%
• Dopamine Receptor D2 10%
• Haloperidol 20%
• N [2 [4 (2 Methoxyphenyl) 1 Piperazinyl]ethyl] N (2 Pyridyl)cyclohexanecarboxamide 20%
• Negative Syndrome 10%
• Partial Agonist 20%
• Rat 100%
• Serotonin 1A Antagonist 10%
• Serotonin 2A Antagonist 10%